Clinical trial,

• Astra slumps as heart drug hit by new setback, a liberal translation
  http://rss.feedsportal.com/c/266/f/3510/s/10b6947a/l/0L0Sindependent0O0Cnews0Cbusiness0Cnews0Castra0Eslumps0Eas0Eheart0Edrug0Ehit0Eby0Enew0Esetback0E21636580Bhtml/story01.htm
  Astrazeneca's ambitions for its Brilinta drug have suffered another blow after US regulators held back their approval and asked for additional analysis of clinical trial data and delaying the launch of the pharma group's much anticipated heart medicine. The American regulation authorities make the approval stagnate and after, request the additional analysis of the clinical test data, can delay the sale of the long-awaited heart medicine of the medicine manufacture group ambition of [asutorazeneka] of the Brilinta medicine has suffered another blow

  ---

  Astrazenecas Ehrgeiz für seine Brilinta Droge hat einen anderen Schlag erlitten, nachdem US-Regler zurück ihre Zustimmung hielten und um zusätzliche Analyse von Studieendaten und -verzögerung der Produkteinführung vieler vorweggenommenen Herzmedizin der pharma Gruppe baten. Die amerikanischen vorgeschriebenen Behörden lassen die Zustimmung und nach stagnieren, fordern die zusätzliche Analyse der klinischen Testdaten, können den Verkauf der langerwarteten Herzmedizin der Medizinfertigunggruppe verzögern, die Ehrgeiz von [asutorazeneka] der Brilinta Medizin einen anderen Schlag erlitten hat
  
  
• Study Finds Early Treatment Can Prevent Spread Of AIDS
  http://www.voanews.com/english/news/africa/Study-Finds-Early-Treatment-Can-Prevent-Spread-Of-AIDS-121834934.html
  Clinical trial shows that when an infected partner gets early treatment and the risk of transmitting the disease to is dramatically reduced As for clinical test, as for the partner who is infected, when early acquiring remedy, the fact that the risk which transmits the sickness is reduced substantially has been shown

  ---

  Klinische Studie zeigt dass, wenn ein angesteckter Partner frühe Behandlung erhält und das Risiko des Übermittelns der Krankheit drastisch verringert wird Was klinischen Test anbetrifft, was den Partner anbetrifft, der angesteckt wird, wenn frühes erwerbenhilfsmittel, die Tatsache, dass das Risiko, das überträgt, die Krankheit verringert wird, im Wesentlichen gezeigt worden ist
  
  
• Why Pfizer's Biggest Experimental Drug Got A Name Change
  http://blogs.forbes.com/matthewherper/2011/03/02/why-pfizers-biggest-experimental-drug-got-a-name-change/
  Earlier this week Pfizer released a neat-o interactive version of its pipeline of experimental drugs and including updates ON which have moved into new clinical trials. This week the [huaiza] corporation, the experimental medicine which includes the renewal program which is being moved to new clinical test, that pipeline did - o interactive release did version securely

  ---

  Assunto para a traducao japonesa.
  
  
• Let's Cut Medicare Waste OFF At The Knees
  http://blogs.forbes.com/larryvanhorn/2011/06/01/lets-cut-medicare-waste-off-at-the-knees/
  In a recent New York Times op-ed and Dr. Rita Redberg identified numerous treatments that Medicare pays for despite offering few positive clinical results – and in a few cases causing potential harm. From unnecessary colonoscopies to ineffective cardiac stents and Dr. Redberg estimates that Medicare could reduction spending by as much as $150 billion -- 30% of the program’ s annual expenditures -- without compromising needed services. As a cardiologist and professor of medicine at the University of California-San Francisco, as well as editor of the Archives of Internal Medicine and Dr. Redberg is eminently well qualified to make those judgments. With several cases which pull up the latent harm - as for the recent new New York times paper the corporation. As for doctor [ritaretsudobagu], offers the result of the Medicare and several correct clinical tests in spite, paying identifies many processing even, a liberal translation

  ---

  In neuem New York Times identifizierenten ein OPEd und Dr. Rita Redberg zahlreiche Behandlungen, die Medicare für trotz das Angebot weniger positiver klinischer Resultate – zahlt; und in einigen Fällen, die möglichen Schaden verursachen. Von den nicht notwendigen Colonoscopies zu den erfolglosen Herzstents und zum Dr. Redberg schätzt, dass Medicare Verkleinerungsausgabe durch soviel wie $150 Milliarde könnte -- 30% des program’ s-Jahrbuchaufwendungen -- ohne kompromittierende erforderliche Dienstleistungen. Als Kardiologe und Professor von Medizin an der Universität von Kalifornien-San Francisco, sowie Herausgeber der Archive der internen Medizin und des Dr. Redberg ist hervorragend gut qualifiziert, jene Urteile zu bilden. Mit einigen Fällen, die den latenten Schaden - was das neue neue New- York Timespapier anbetrifft die Korporation hochziehen. Was Doktor anbetrifft [ritaretsudobagu], identifizierent Angebote das Resultat der Medicare und einige korrekte klinische Tests in der Bosheit, zahlend viel sogar verarbeiten
  
  
• How Comparative Effectiveness Research Gets Corrupted by Politics
  http://blogs.forbes.com/aroy/?p=1190
  I’ m a supporter, in principle and of comparative effectiveness research. Comparative effectiveness research involves running large and statistically robust clinical trials so we can judge how different therapies for a particular disease compare to each other. Indeed and the private sector spends hundreds of billions of dollars a year ON such research— not that you would know it from the way the issue is discussed in the media. Ratio. Principlly of effective research my supporter,

  ---

  Assunto para a traducao japonesa.
  
  
• AHA 2011 in Orlando: Late-Breaking Clinical Trials, a liberal translation
  http://www.forbes.com/sites/larryhusten/2011/08/16/aha-2011-in-orlando-late-breaking-clinical-trials/
  Late-Breaking Clinical Trials I. Sunday and Nov 13 and 2011, 3:45 PM - 5:13 PM West Hall B4 Moderators:   Jeffrey Weitz, Hamilton, ON and Canada;   Gilles Montalescot and Paris, France 3:45 PM: Intracoronary Compared with Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention: AIDA STEMI Trial Holger Thiele, Herzzentrum Leipzig, Leipzig and Germany; Jochen Wö hrle, Univ of Ulm, Ulm and Germany; Rainer Hambrecht, Klnikum Links der Weser, Bremen and Germany; Harald Rittger, Klnikum Coburg, Coburg and Germany; Ralf Birkemeyer, Klnikum Villingen-Schwenningen, Villingen-Schwenningen and Germany; Bernward Lauer, Zentralklinik Bad Berka, Bad Berka and Germany; Petra Neuhaus, Oana Brosteanu, KKSL, Leipzig and Germany; Peter Sick and Krankenhaus Barmherzige Brü der, Regensburg and Germany; Marcus Wiemer, HERHerz- und Diabeteszentrum NRW, Bad Oeynhausen and Germany; Sebastian Kerber and Herz- und Gefä ß - Klinik, Bad Neustadt and Germany; Ingo Eitel, Herzzentrum Leipzig, Leipzig and Germany; Klaus Kleinertz, Ambulantes Herzzentrum Chemnitz, Chemnitz and Germany; Gerhard Schuler, Herzzentrum Leipzig, Leipzig and Germany Discussant:   Alice K Jacobs, Boston and MA Up-to-date clinical test I. 2011 November 13th (Sunday), 15: 45 - 17:13 west hole B4 moderator: Canada, ON [jiehuriueitsu], Hamilton, and gill Montalescot, Paris and France 15: 45: In comparison with inside the crown artery, [yotsuhen]. The university of öhrle, [urumu], [urumu] and Germany, [rainahanburehito] and Klnikum [rinkuderuvueza], Bremen, %, a liberal translation

  ---

  Klinische Studien Spät-Brechen I. Sonntag und 13. November und 2011, 3:45 P.M. - 5:13 P.M. Westhall B4 Moderatoren:   Jeffrey Weitz, Hamilton, AN und Kanada;   3:45 P.M. Gilles-Montalescot und Paris, Frankreich: Intracoronary verglich mit intravenöser Bolus Abciximab Anwendung während der perkutanen kranzartigen hauptsächlichintervention: AIDA STEMI Probeholger Thiele, Herzzentrum Leipzig, Leipzig und Deutschland; Jochen Wö hrle, Univ von Ulm, von Ulm und von Deutschland; Rainer Hambrecht, Klnikum verbindet der Weser, Bremen und Deutschland; Harald Rittger, Klnikum Kammgarn-stoff, Kammgarn-stoff und Deutschland; Ralf Birkemeyer, Klnikum Villingen-Schwenningen, Villingen-Schwenningen und Deutschland; Bernward Lauer, Zentralklinik schlechtes Berka, schlechtes Berka und Deutschland; PETRA Neuhaus, Oana Brosteanu, KKSL, Leipzig und Deutschland; Peter-Kranker und Krankenhaus Barmherzige Brü der, Regensburg und Deutschland; Marcus Wiemer, HERHerz- und Diabeteszentrum NRW, schlechtes Oeynhausen und Deutschland; Sebastian Kerber und Herz- und Gefä ß - Klinik, schlechtes Neustadt und Deutschland; Ingo Eitel, Herzzentrum Leipzig, Leipzig und Deutschland; Klaus Kleinertz, Ambulantes Herzzentrum Chemnitz, Chemnitz und Deutschland; GerhardSchuler, Herzzentrum Leipzig, Leipzigund DeutschlandDiscussant:   Alice K Jacobs, Boston und MA Aktueller klinischer Test I. 13. November 2011 (Sonntag), 15:45 - Moderator des 17:13westlochs B4: Kanada, AN [jiehuriueitsu], Hamilton und Kieme Montalescot, Paris-und Frankreich-15:45: Im Vergleich mit innerhalb der Kronenarterie [yotsuhen]. Die Universität von öhrle, [urumu], [urumu] und Deutschland, [rainahanburehito] und Klnikum [rinkuderuvueza], Bremen und Deutschland Halard Rittger, AIDA STEMI Urteil [horugateira], Herzzentrum Leipzig und [raiputsuihi], Deutschland: Shaun Primärhautkronenarterie inter- Venn
  
  
• Spanish HIV Vaccine Shows 90 Percent Success in Early Trial
  http://www.voanews.com/english/news/health/Spanish-HIV-Vaccine-Shows-90-Success-in-Early-Trial-131013313.html
  Promising results pave way for further clinical trials ON HIV-infected volunteers The promising result opens the road to further clinical test of the volunteer of the person who is infected to HIV, a liberal translation

  ---

  Viel versprechende Resultate ebnen Weise für weitere klinische Studien AUF HIV-angesteckten Freiwilligern Das viel versprechende Resultat öffnet die Straße zum weiteren klinischen Test des Freiwilligers der Person, die zu HIV angesteckt wird
  
  
• UN Prosecutors Seek 2 Separate Trials for Mladic
  http://www.voanews.com/english/news/europe/UN-Prosecutors-Seek-2-Separate-Trials-for-Mladic-127927923.html
  Prosecutors express concern that Ratko Mladic's health may deteriorate before an all-encompassing trial is completed As for investigation before all inclusive clinical tests complete, stating the anxiety that the health of Ratko Mladic decreases,, a liberal translation

  ---

  Verfolger ausdrücken Interesse er, dass Ratko Mladics Gesundheit verschlechtern kann, bevor ein all-encompassing Versuch abgeschlossen Was Untersuchung anbetrifft vor allen einschließlichen klinischen Tests abschließen Sie und die Angst angeben, die die Gesundheit von Ratko Mladic verringert,
  
  
• Regeneron Announces Strong Results In Gout Study
  http://blogs.forbes.com/matthewherper/2011/02/28/regeneron-announces-strong-results-in-gout-study/
  Regeneron Pharmaceuticals of Tarrytown and N.Y., announced positive results from a second late-stage clinical trial showing that its drug Arcalyst, currently approved for a rare disease, can treat gout and a much more lucrative opportunity. As for the [rijieneron] medical supply of tally town and New York, as for that medicine Arcalyst which presently for the rare disease is approved, much the profitable opportunity the affirmative result was announced from the second latter term of the clinical test which shows the fact that it can handle the gout

  ---

  Regeneron pharmazeutische Produkte von Tarrytown und von N.Y., verkündete positive Ergebnisse von einer zweiten Spätstadium Studieenvertretung, dass seine Droge Arcalyst, z.Z. genehmigt für eine seltene Krankheit, Gicht und eine viel lukrativere Gelegenheit behandeln kann. Was den [rijieneron] medizinischen Bedarf anbetrifft der Tally Stadt und des New York, was diese Medizin anbetrifft Arcalyst, die momentan für die seltene Krankheit anerkannt ist, viel wurde die rentable Gelegenheit das bestätigende Resultat vom zweiten letzten Ausdruck des klinischen Tests verkündet, der der Tatsache zeigt, dass er die Gicht behandeln kann
  
  
• Repligen Shares Hammered and Green Dot Sees Red, a liberal translation
  http://www.forbes.com/2011/03/07/todays-big-losers-rgen-gdot-marketnewsvideo.html
  Repligen announced ON Monday that a mid-stage clinical trial showed one that its drug, RG2417, also known as uridine and was not significantly better than a placebo in treating bi-polar depression. As for Repligen, as for the medicine which is known clinical test of midcourse phase as the gourd, RG2417, substantially both parties. At the time of remedying of the polarity melancholia, it announced in Monday that the fact that it is not done compared to [purasebo] is shown

  ---

  Repligen verkündete am Montag, dass eine Mittlerstadium klinische Studie ein dass seine Droge, RG2417 zeigte, alias Uridin und nicht erheblich besser als ein Placebo war, wenn sie zweipoligen Tiefstand behandelte. Was Repligen anbetrifft, was die Medizin anbetrifft, die bekannter klinischer Test der Mittelkursphase als der Kürbis, RG2417, im Wesentlichen beide Parteien ist. Zu der Zeit der Behebung des Polarität Melancholia, verkündete sie in Montag, dass die Tatsache, dass sie nicht erfolgt, als [purasebo] gezeigt
  
  
• Today's Big Losers: RGEN and GDOT
  http://video.forbes.com/fvn/market-updates/todays-big-losers-rgen-gdot
  Repligen (RGEN) announced ON Monday that a mid-stage clinical trial showed one that its drug, RG2417 and [...] Repligen (RGEN) showing the clinical test of midcourse phase to announce in Monday, that medicine, RG2417 and the [...

  ---

  Repligen (RGEN) am Montag verkündet, dass eine Mittlerstadium klinische Studie einer zeigte, dass seine Droge, RG2417 und [...] Repligen (RGEN) den klinischen Test der Mittelkursphase zeigend, um in Montag, diese Medizin, RG2417 zu verkünden und […
  
  
• Why Contract Research Organizations Are So Hot
  http://www.forbes.com/sites/edsilverman/2011/10/04/why-contract-research-organizations-are-so-hot/
  With more drugmakers outsourcing more trials to contract research organizations and few should be surprised that the CRO sector is generating investor interest. The attention-grabbing deal announced this week in which two private equity firms - Carlyle Group and Hellman & Friedman - agreed to pay $3.9 billion in cash to buy Pharmaceutical Product Development is no random bet. As for more many medicine manufacture companies, when many clinical tests the out-sorcing are done in the depositoty, as for several, it is the expectation which is surprised to CRO section having formed the interest of the investor

  ---

  Mit mehr Arzneimittelherstellern sollte die Auslagerung von mehr Versuchen, um der Forschungsorganisationen und Vertrag weniger abzuschließen überrascht sein, dass der KUNDENBERATERIN-Sektor Investorinteresse erzeugt. Das Aufmerksamkeit-ergreifenabkommen verkündete diese Woche, in der zwei private Billigkeitsunternehmen - Carlyle Gruppe und Hellman & Friedman - war damit einverstanden, $3.9 Milliarde im Bargeld zu zahlen, um pharmazeutisches Produkt-Entwicklung zu kaufen ist keine gelegentliche Wette. Was viele Medizinfertigungfirmen anbetrifft, wenn viele klinischen Tests das Out-sorcing im depositoty durchgeführt werden, was mehrere anbetrifft, es ist die Erwartung, die zum KUNDENBERATERIN-Abschnitt überrascht ist, der das Interesse des Investors gebildet wird
  
  
• Letters:
  http://www.guardian.co.uk/business/2011/mar/15/eu-drug-trials-law
  Ben Goldacre raises important concerns about revolving doors and lack of transparency at the European medicines regulator (Bad science and 5 March). The European commission has now referred the case of Thomas Lonngren, who left to the European Medicines Agency to go into consultancy, to the EMA management board and which will decide what action to take. I recognise Goldacre's wider concerns ON transparency. The old system left a lot to be desired. But the legislation has just been revised and FULL details about drug-safety meetings will be put online, including minutes and recommendations for decision (including divergent positions). Public hearings will even be held. And as for clinical trials and a public version of the EMA's clinical trials' database goes live this week. There is also due to be an overhaul of clinical trial laws next year and which is an opportunity to resolve  any outstanding issues. Linda McAvan MEPLabour European spokesperson ON health and rapporteur ON pharmacovigilancePharmaceuticals industryEuropean commissionEuropean Unionguardian.co.uk © Guardian News & Media Limited 2011 | Use of this content is subject to our Terms & Conditions | More Feeds As for Venn Goldacre, occurs important anxiety concerning the lack of the rotary door and transparency (bad science, March 5th) with the European medical supply regulator

  ---

  Ben Goldacre aufwirft wichtige Interessen über Drehtüren und Mangel an Transparent am europäischen Medizinregler in (schlechte Wissenschaft und 5. März). Die Europäische Kommission verwiesen jetzt den Fall von Thomas Lonngren, der der europäische Medizin-Agentur verließen, um in Beratung, zum EMA-Verwaltungsrat einzusteigen und der entscheidet, welche Tätigkeit zum zu nehmen. Ich erkenne Goldacres breitere Interessen AUF Transparent. Das alte System verließ viel gewünscht zu werden. Aber die Gesetzgebung gerade verbessert worden und GESAMTE Details über Drogesicherheit Sitzungen gesetzt online, einschließlich Minuten und Empfehlungen für Entscheidung (einschließlich unterschiedliche Positionen). Öffentliche Anhörungen sogar gehalten. Und was klinische Studien und eine allgemeine Version anbetrifft der Datenbank der klinischen Studien des EMAS auf den Markt kommt diese Woche. Es gibt auch, eine Überholung der Studieengesetze zu sein nächstes Jahr und das eine Gelegenheit zum resolve  ist; irgendwelche hervorragenden Ausgaben. Europäischer Sprecher Linda-McAvan MEPLabour AUF Gesundheit und Referent AUF pharmacovigilancePharmaceuticals industryEuropean commissionEuropean Unionguardian.co.uk © Wächter-Nachrichten u. Mittel begrenzten 2011 | Gebrauch von diesem Inhalt ist abhängig von unseren Ausdrücken u. Bedingungen | Mehr einzieht ht Was Venn anbetrifft Goldacre, erzeugt wichtige Angst hinsichtlich des Fehlens von der Drehtür und dem Transparent (schlechte Wissenschaft, 5. März) mit dem europäischen Bedarfsregler
  
  
• These are many word of blog in Japanese the most recent topics.
  http://dealbook.blogs.nytimes.com/2010/11/02/french-doctor-arrested-on-insider-trading-charges/?partner=rss&emc=rss
  A prominent French doctor has been arrested ON criminal fraud charges that accused him of tipping OFF a hedge fund manager about setbacks in a clinical drug trial that had not yet been made public. The prominent French doctor in off inversion, has been arrested with clinical test of the medicine which is not published yet the hedge fund manager with the crime fraud suspicion which criticized him concerning collapse

  ---

  Ein vorstehender französischer Doktor festgehalten worden AUF Gebühren des kriminellen Betrugs ugs, die ihn vom Neigen WEG VON einem Fondmanager über Rückschläge in einem klinischen Drogeversuch beschuldigten, der nicht noch allgemein gebildet worden. Der vorstehende französische Doktor weg von in der Umstellung, festgehalten worden mit klinischem Test der Medizin, die nicht veröffentlicht, dennoch dem Fondmanager mit dem Verbrechenbetrugsmisstrauen ugs, das ihn hinsichtlich des Einsturzes kritisierte
  
  
• New
  http://www.themoscowtimes.com/article/416878.html
  Clinical testing of medication may become illegal in Russia after the government issued insurance requirements for participating patients that are practically impossible to satisfy. As for government as for making be satisfied substantially the patient who is impossible after issuing the insurance important matter in order to participate, clinical test of the medicine in Russia are times when it becomes illegal

  ---

  Klinische Prüfung der Medikation kann in Russland nach den Regierung herausgegebenen Versicherungsanforderungen für teilnehmenpatienten ungültig werden, die praktisch unmöglich zufriedenzustellen sind. Was Regierung anbetrifft was die Herstellung anbetrifft im Wesentlichen dem Patienten zufrieden gestellt Sie seien, der nach der Ausgabe der wichtigen Angelegenheit der Versicherung, um teilzunehmen unmöglich ist, sind klinischer Test der Medizin in Russland Zeiten, als es ungültig wird
  
  
• Stem cells: A factfile
  http://www.bangkokpost.com/breakingnews/200858/stem-cells-a-factfile
  Embryonic stem cells have crossed a threshold with the announcement Monday that this novel but also contested treatment has moved out of the lab and into a clinical trial. As for the germ cell not only this novel, as for remedy of fierce battle, moving outside the laboratory as for announcement to clinical test Monday and the trunk which exceeds threshold value

  ---

  Embryonale Stammzellen haben eine Schwelle mit der Ansage Montag überschritten, dass dieser Roman aber auch gewetteiferte Behandlung sich aus dem Labor heraus und in eine klinische Studie bewogen hat. Was die Mikrobezelle anbetrifft nicht nur dieser Roman, als für das Hilfsmittel des heftigen Kampfes, beweglich außerhalb das Labor was Ansage anbetrifft zum klinischen Test Montag und zum Stamm, der Schwellenwert übersteigt
  
  
• These are many word of blog in Japanese the most recent topics.
  http://www.scmp.com/vgn-ext-templating/v/index.jsp?vgnextoid=d6d6812fd593b210VgnVCM100000360a0a0aRCRD&s=Business
  Global drug firms have embarked ON clinical trials for diseases prevalent among Chinese people, an area they had previously ignored and as they jostle to develop products targeted at the mainland's massive and ageing population. As for them large-scale of the mainland and aging of population developing the product in the target, between the sickness Chinese of the worldwide medical supply company of the ferryboat starting the clinical test for becoming popular people, the area, ignored in the past

  ---

  Globale Drogeunternehmen haben MIT klinischen Studien für die Krankheiten gebegonnen, die unter chinesischem Volk, ein Bereich überwiegend sind, den sie vorher ignoriert hatten und wie sie drängeln, um die Produkte zu entwickeln, die auf das massive Festland und alternde Bevölkerung abgezielt werden. Wie für sie großräumig vom Festland und vom Altern der Bevölkerung das Produkt im Ziel, zwischen dem Krankheit Chinesen der weltweiten Bedarfsfirma der Fähre entwickelnd, die den klinischen Test für werdene populäre Leute, der Bereich, in der Vergangenheit ignoriert beginnt
  
  
• These are talking of Japanese blogoholic.
  http://www.guardian.co.uk/society/sarah-boseley-global-health/2010/aug/13/vaccines-millennium-development-goals
  Trials show a new vaccine can slash deaths from diarrhoea and which kills half a million children in poor countries every year. But will donors have to choose between paying for that or supporting Aids and TB and malaria care? Good news at the end of last week - rotavirus vaccine works in Africa and Asia, protecting children against diarrhoea and one of their biggest killers. Trial results published in the Lancet clearly show that vaccines which are already licensed for use in the wealthier parts of the world can save lives in poor countries too. Severe rotavirus gastroenteritis kills half a million children a year. Even before these trials and the World Health Organisation had recommended all countries introduce the vaccine. This is Dr John C Victor of PATH in Seattle and which helped run trials in Bangladesh and Vietnam: With a WHO recommendation for rotavirus vaccines now in place and governments of developing countries in Africa and Asia are deciding how to prioritise introduction of rotavirus vaccine in their public health agendas. Our trial shows that a live oral rotavirus vaccine has the potential to halve the incidence of severe rotavirus gastroenteritis in developing populations in Asia. Alongside efficacy results for this vaccine in Africa and our study supports WHO's strong recommendation for expansion of rotavirus vaccine use to the poorest nations in Africa and Asia. Rotavirus vaccines have the potential to protect the lives of nearly 2 million children in the next decade alone. And here are Dr George E Armah, University of Ghana, and Dr Kathleen M Neuzil, also of PATH and who ran the Africa trial: In Africa, where Young children are dying from diarrhoeal disease and prompt medical care is often out of reach and the need to prevent rotavirus is especially urgent. Introduction of rotaviru As for test, as for the new vaccine, the fact that the diarrhea and the death which every year kill 500,000 children in poor countries can be reduced substantially is shown

  ---

  Assunto para a traducao japonesa.
  
  
• Pfizer set up research center in Wuhan
  http://english.people.com.cn/90001/90776/90882/7161093.html
  Pfizer Chairman and CEO Jeff Kinder announced that a global research and development center for radiation biology and drug development has been officially established in Wuhan, capital of central China's Hubei Province and where he arrived ON the same day by his special plane. Wuhan Pfizer R&D center will provide intellectual support for the company's clinical drug development projects in the world and including clinical trials from Phase I to IV, and will carry out deep collaboration with local i… The center D of [huaiza] chairman and the Jeff children of CEO as for radiation biology for development center and the worldwide research which is announced, the medicine [huaiza] military affairs of &R. It develops

  ---

  Pfizer-Vorsitzender und CEO Jeff freundlicheres verkündet, dass eine globale Entwicklungmitte für Strahlungsbiologie und Drogeentwicklung offiziell in Wuhan, Kapital der Hubei-Provinz der Zentralchina hergestellt worden ist und wo er am gleichen Tag mit seinem speziellen Flugzeug kam. Wuhan Pfizer R&D-Mitte gewährt intellektuelle Unterstützung für die klinischen Droge-Entwicklungsprojekte der Firma in der Welt und Einschließenklinische Studien von Phase I bis IV und führt tiefe Zusammenarbeit mit Einheimischem I… durch Die Mitte D [huaiza] des Vorsitzenden und der Jeff-Kinder CEOs was Strahlungsbiologie für Entwicklungszentrum und die weltweite Forschung anbetrifft, die verkündet wird, die Militärangelegenheiten der Medizin [huaiza] von &R. Es entwickelt sich
  
  
• Japanese talking
  http://blog.goo.ne.jp/arai647/e/cf829ff4a60f1adae1d922f86e6788d6
  we are taking forward this transplant drug with a chip and

  ---

  wir nehmen vorwärts diese Transplantationdroge mit einem Span und
  
  
• Japanese Letter
  http://www.smh.com.au/world/stemcell-therapy-to-begin-on-humans-20100731-110kg.html
  

  ---

  NEW YORK: Das US-Behörde zur Überwachung von Nahrungs- und Arzneimitteln (FDA) hat das all-freie zu einer klinischen Studie der embryonalen Stammzellen als Behandlung für Spinalschnur Verletzung gegeben. New York: Das amerikanische NahrungsmittelBedarfsbüro (FDA) hat zum klinischen Test der charakteristischen Stammzelle des Embryos völlig offenbar als Hilfsmittel des Rückenmarkschadens gegeben
  
  
• original letters
  http://www.guardian.co.uk/society/sarah-boseley-global-health/2010/sep/07/antibiotics-drug-resistance
  Drug resistance is fast destroying the POWER of antibiotics. Tighter infection control and incentives for drug companies to invent more antibiotics are usually proposed as the answer. But the authors of a new paper say we have to think out of the box. What are we to do about the diminishing POWER of antibiotics - once the miracle drugs that looked set to end infectious diseases? We know the problem is becoming very serious - here is a piece I wrote about the alarming prospects for a future without antibiotics. But we don't hear much in the way of imaginative answers. So it's refreshing to read a paper out this morning from Aaron Kesselheim, from Brigham and Women's Hospital and Harvard Medical School in Boston, and Kevin Outterson, a professor at Boston University Law School.Their analysis, published in the journal Health Affairs, says the usual idea, to give pharmaceutical companies financial incentives to invent and manufacture more antibiotics and won't work. One of the reasons we are in this parlous state of affairs, they say and is that drug companies in the past have tried too hard to sell more tablets. Of course and the misuse of the drugs - physicians over-prescribing and patients not completing the course - is largely to blame and but companies have been disciplined for promoting wrong uses of antibiotics. They cite two cases involving Pfizer. In one of those and in 2005, the company, they say and was warned by the Food and Drug Administrationthat its 'misleading promotion' of linezolid (Zyvox) as a treatment for a wide range of methicillin-resistant Staphylococcus aureus (MRSA) infections 'poses serious public health and safety concerns because of its potential to result in inappropriate use'. The FDA concluded that the clinical trial data did not support linezolid's use for thos Medicine tolerance has destroyed the power of the high-speed antibiotic

  ---

  Drogewiderstand ist schnell, die ENERGIE der Antibiotika zerstörend. Festere Infektionsteuerung und -anreize, damit Drogenfirme mehr Antibiotika vorgeschlagen normalerweise als die Antwort erfinden. Aber die Autoren von einem neuen Papier sagen, dass wir aus dem Kasten heraus denken müssen. Was sind wir, zum über die vermindernde ENERGIE der Antibiotika zu tun - einmal die Wunderdrogen, die Satz schauten, um Infektionskrankheiten zu beenden? Wir wissen, dass das Problem sehr ernst wird - ist hier ein Stück, das ich über die Besorgnis erregenden Aussichten während einer Zukunft ohne Antibiotika schrieb. Aber wir hören nicht viel auf die Art der fantasiereichen Antworten. So erneuert es, um ein Papier heute morgen von Aaron Kesselheim, Brigham und der Frauen vom Krankenhaus und von der Harvard-Medizinischen Fakultät in Boston und Kevin Outterson, ein Professor vorzulesen an der Analyse des Boston-Hochschulgesetzes School.Their, veröffentlicht in den Journal Gesundheits-Angelegenheiten, sagt die übliche Idee, pharmazeutischen Unternehmen Finanzanreize zu geben, um zu erfinden und mehr Antibiotika herzustellen und funktionieren nicht. Einer der Gründe sind wir in dieser parlous Sachlage, sagen sie und sind, dass Drogenfirme in der Vergangenheit zu stark versucht, mehr Tabletten zu verkaufen. Selbstverständlich und der Missbrauch der Drogen - das Arztüber-vorschreiben und -patienten den Kurs nicht abschließend - groß, diszipliniert worden für die Förderung des falschen Gebrauches der Antibiotika ist zu tadeln und aber Firmen. Sie zitieren zwei Fälle, die Pfizer mit.einbeziehen. In einem von denen und 2005, die Firma, sagen sie und gewarnt durch die Nahrung und Droge Administrationthat seine „irreführende Förderung“ von linezolid (Zyvox) als Behandlung für eine große Auswahl der Methicillin-beständigen Infektion des Staphylococcus aureus (MRSA) „aufwirft ernste öffentliches Gesundheitswesen- und Sicherheitsinteressen wegen seines möglichen es, um nicht angebrachten Gebrauch zu ergeben“. Die FDA feststellte os, dass die Studieendaten nicht Gebrauch der linezolids für thos stützten Medizintoleranz zerstört die Energie des Hochgeschwindigkeitsantibiotikums
  
  
• original letters
  http://www.guardian.co.uk/world/2010/apr/04/wallace-fox-obituary
  Medical researcher who revolutionised the treatment of TBWallace Fox and who has died aged 89, was the leader of the Medical Research Council (MRC) programme that developed the standard worldwide treatment of tuberculosis. TB sanatoriums closed by the end of the 1960s after he showed that home treatment was just as good and then he shortened the period of treatment from a year to six months. The work he did at the MRC tuberculosis research unit, in collaboration with many researchers elsewhere and helped change TB from being an untreatable disease to one that can be alleviated in both rich and poor countries - a major medical advance. Wallace was Born in Bristol, where he attended Cotham grammar school, and undertook his medical education in London at Guy's hospital, followed by hospital posts at Guy's, Preston Hall sanatorium, Kent and then in London at the Hammersmith chest clinic. He caught TB himself soon after medical qualification, and was treated with bed rest for two years at the Bristol Royal Infirmary.He joined the staff of the MRC tuberculosis research unit, directed by Philip D'Arcy Hart and in 1952. At that time, half of those who developed TB died from it, but new anti-bacterial drugs, such as streptomycin and isoniazid and were being introduced to treat the disease. The principal method for TB control then considered by the World Health Organisation (WHO) was BCG (Bacillus Calmette-Guérin) vaccination. But Wallace took an early decision to concentrate ON treatment and thus anticipating a later change in WHO policy.TB treatment was primitive. The first clinical trial had shown that treatment with streptomycin alone resulted in drug-resistant tubercle bacilli. But when streptomycin was combined with PAS (para-aminosalicylic acid) or, better and with the more potent isoniaz The TBWallace fox, died the medical researcher who brings revolution to remedy medical research council (MRC) worldwide standard remedy of the tuberculosis was the leader of the development program in 89 years old

  ---

  Assunto para a traducao japonesa.
  
  
• Indo-Pakistani talks require caution | Anita Inder-Singh
  http://www.guardian.co.uk/commentisfree/2010/apr/30/india-pakistan-talks-caution
  The resumption of dialogue between India and Pakistan is welcome and but expectations of its outcome should be kept lowDoes the decision taken by prime ministers Manmohan Singh and Yusuf Raza Gilani to resume dialogue to settle differences between India and Pakistan offer a chance to open the DOOR to greater regional and international security? If so and the latest summit of the eight-member South Asian Association for Regional Cooperation (SAARC) in Thimpu and the capital of the Himalayan kingdom of Bhutan - which served as the occasion for the Singh-Gilani meeting - could turn out to be most memorable since its creation in 1985.Dominated by South Asia's two arch-rivals, India and Pakistan, SAARC is, in the words of India's Singh and a glass half-empty. The Indo-Pakistani schism over Kashmir is the main reason why SAARC has yet to craft the norms of co-operation that could improve the management of natural resources, prevent land and water degradation and increase human security in South Asia.So will the resumption of dialogue ease tensions between India and Pakistan? The decision is welcome and but expectations about its outcome should be kept low. The most recent barrier to dialogue has been Islamabad's refusal to act against the seven Lashkar-e-Taiba (LeT) men currently ON trial in Rawalpindi for their involvement in the November 2008 terrorist attacks in Mumbai. And India says that the last few months have seen a rise in extremist forays into India's half of Kashmir (Jammu and Kashmir). Gilani has promised that Pakistani territory will not be misused to launch terrorist assaults ON India. But similar complaints and promises have been made in the past and New Delhi is not convinced that Islamabad intends to stop using militants as an instrument of state policy. Whether extremist inf As for India and Pakistan being welcomed, reopening the conversation between, the opposite which photographed the decision which has the necessity for expectation of the result to be maintained with prime minister [manmohanshinyusuhurazagirani

  ---

  Assunto para a traducao japonesa.
  
  
• Japanese weblog
  http://www.guardian.co.uk/science/blog/audio/2010/jun/07/science-weekly-podcast-world-cup-2010
  Steve Haake, head of sports engineering at Sheffield Hallam University and joins us to explain why altitude could make the difference between triumph and disaster at World Cup 2010 in South Africa. He also predicts that goalkeepers will be moaning about the design of the balls. Steve will be giving a talk at the Royal Institution ON 8 June. We look at some of your responses to last week's live recording of this podcast at the Science Museum in London. Following a discussion at the Hay Festival ON 10 years of the Human Genome Project, we reveal what Nobel laureates John Sulston and Martin Evans, and Michael Morgan, former CEO of the Wellcome Trust Genome Campus and had to say about Craig Venter's creation of the world's first synthetic genome. We visited the Royal Society's exhibition celebrating its 350th anniversary. Keith Moore, its librarian and tells us about Robert Boyle's list of scientific ambitions. View a gallery of the Royal Society exhibition here. In the newsjam we discuss the ban ON mephedrone, trials to begin ON a breast cancer vaccine, a resignation over GM foods and why six men will be spending 520 days locked inside a spaceship in a Moscow car park. Guardian science correspondent Ian Sample and Observer science editor Robin McKie were ON hand in the studio to throw around the World Cup ball. WARNING: contains strong language. Follow the podcast ON our Science Weekly Twitter feed and receive updates ON all breaking science news stories from Guardian Science. Email scienceweeklypodcast@gmail.com. Join our Facebook group. Listen back through our archive. Subscribe free via iTunes to ensure every episode gets delivered. (Here is the non-iTunes URL feed). Alok JhaAndy DuckworthIan SampleRobin McKieJohn Sulston Us why altitude explains the victory with 2010 W cup of the Republic of South Africa and the fact that the difference of disaster is made connects the length of [suteibuhaeku] and [shiehuirudoharamu] university sport engineering,

  ---

  Assunto para a traducao japonesa.
  
  
• Investors look to foreign media
  http://english.people.com.cn/90001/90778/90860/6930895.html
  Chinese private investment in Southeast Asian Nations (ASEAN) has now extended to the media sector. ASEAN Finance, a Chinese business magazine established by three businessmen in Anhui Province, will soon debut in both ASEAN countries and China and said CEO Hsin Ling Chi at a press conference held in Beijing Thursday. The bimonthly magazine and authorized by Singaporean authorities September 28, is now running trials and initiating an investigation ON Chinese enterprises' investment in the ASEAN r… The Association of Southeast Asian Nations (ASEAN) the Chinese private investment the media section which now directly carries out the debut in both ASEAN countries and China

  ---

  Chinesische Privatinvestition in den asiatischen Südostnationen (ASEAN) hat jetzt auf Mittel den Sektor verlängert. Asean-Finanzierung, eine chinesische Handelszeitung, die von drei Geschäftsmännern in der Anhui-Provinz hergestellt wird, debut bald in den ASEAN-Ländern und China und besagtes Chi CEO-Hsin Ling bei einer Pressekonferenz, die in Peking Donnerstag gehalten wird. Die zweimonatliche Zeitschrift und autorisiert durch Singaporeanbehörden 28. September, jetzt macht Versuche und leitet eine Untersuchung AUF Investition der chinesischen Unternehmen im ASEAN r… ein In der Verbindung der asiatischen Südostnationen (ASEAN) die chinesische Privatinvestition der Mittelabschnitt, der jetzt direkt den Anfang in den ASEAN-Ländern und in China durchführt
  
  
• Terrorists don't stand still and neither can we | Chris Huhne
  http://www.guardian.co.uk/commentisfree/libertycentral/2010/jan/06/body-scanners-airports-terrorism
  If they are effective and available and body scanners at airports should have been rolled out by the government years agoNo one wants to have FULL body scanners in airports. No one wants to be electronically strip-searched at the START of their holidays. It is an invasion of privacy we would all rather avoid. But the foiled bombing attempt ON a Detroit-bound plane over Christmas demonstrates that terrorists still have an unhealthy addiction to air travel and we have to move with the developing threat. Terrorists do not stand still and neither can we. The government's assessment is that there would have been a 60 percent chance of identifying the explosive ON Umar Farouk Abdulmutallab had he been scanned. I agree that the timing of the government's announcement is not great. In the aftermath of an attack or an attempted attack and such policies are a visible way for a government to demonstrate that it is taking action. However and four of these £100,000 machines have lain in storage in Heathrow despite successful trials over the last few years. Seventeen of these machines remain mothballed in Amsterdam's Schiphol airport and where the would-be bomber Abdulmutallab stopped OFF in transit. The government has been in no rush to introduce what we are now being told is an effective way of detecting would-be bombers. This is not acceptable. If they are effective, tested and available, they should have been rolled out years ago, and not as a knee-jerk reaction to an attempted terrorist attack in the United States.Too often and the immediate response to terror attacks or the threat of terror attacks has been disproportionate. For example, there was the proposal for 90 days detention without charge, the Belmarsh provisions locking people up by ministerial fiat and control orders imposing house ar If there is an effect, to be, as for the body scanner at the airport, as for government the necessity rollback to be done requiring the full body scanner at one airport with year, agoNo

  ---

  Assunto para a traducao japonesa.